Friday , January 21 2022

Good news! They achieved 90 percent success



[ad_1]

"REGN-EB3", "mAb114", "ZMapp" and "Remdesivir" on approximately 700 patients with KDC ebola, according to a statement from the US National Institute of Allergy and Infectious Diseases (NIAID). "I called drugs.

When the drugs "REGN-EB3" and "mAb114" were developed with antibodies from persons recovering from the virus, improvement was achieved in 94 percent of cases where people received early Ebola virus in their bodies.

Drugs, given the disease in the later stages of "REGN-EB3", a recovery rate of 71 percent of patients taking "mAb114" also improved 66 percent of patients.

"The first drugs to significantly reduce mortality from Ebola patients"

"REGN-EB3" and "mAb114" are "the first drugs to significantly reduce the mortality of Ebola patients" in a scientific health study, said NIAID Director Dr. Anthony Foci.

Developed drugs are expected to be used in epidemic areas in a short time.

At the recent outbreak of Ebola in KDC, the death rate is 67 percent.

The number of those who lost their lives in the epidemic reached 800,000

On the other hand, the death toll from the Ebola epidemic, which began in late July at KDC last year, reached 797,000.

According to data shared by the Ministry of Health, North Kivu and Ituri province, 2,000 737 people have been diagnosed with the Ebola virus in 2,831 cases of hemorrhagic fever.

Ministry, Ebola's thousands of 797 people lost their lives and 94 cases of bleeding from bleeding, possibly due to Ebola's.

On the other hand, 826 people carrying the virus were cured while the treatment of 114 people at the Ebola centers continued.

The campaign started on August 8, 2018 and nearly 200,000 people have been vaccinated.

The Ebola virus, which caused some type of bleeding fever, first appeared in 1976 with two concurrent outbreaks in Nzara in Sudan and Yambuku in the FTC. As the outbreak at KDC begins in a village near the Ebola River, it is named after the river.

The Ebola virus spread in December 2013 in West Africa. In the 2014-2017 epidemic in Guinea, Liberia and Sierra Leone, 30,000 people were infected and over 11,000 were killed.

[ad_2]
Source link